Gemini Biosciences launches new proteomics and antibody services

We are delighted to introduce our new proteomics and antibody services designed for scientists and researchers developing biopharmaceuticals including bio-similar therapeutic antibodies and comparability studies. The services could also be useful for research scientists who wish to better characterise their reagents prior to use in their research projects.


The new proteomics services we have introduced include: C termini sequencing of proteins

complete peptide mappingdisulfide bond and protein glycosylation analyses.


As regards new antibody services, we are now offering monoclonal antibody (mAB) impurity 

and sequence variant analysis and complete de novo sequencing of monoclonal antibodies,

which makes use of our excellent proteomics services.





Please visit our website for more information about our processes and the applications of these research services.

Please reload

Featured Posts

Analysis of extracellular vesicles service

November 25, 2019

Please reload

Recent Posts
Please reload

Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Find us

Liverpool Bio-Innovation Hub 

William Henry Duncan Building

6 West Derby Street


L7 8TX

United Kingdom


t: +44 (0) 151 794 9317 


Copyright © 2015 Gemini Biosciences Ltd